Prognostic value of the 6-min walk test derived attributes in patients with idiopathic pulmonary fibrosis

被引:2
|
作者
Bloem, Ada E. M. [1 ,2 ,3 ]
Dolk, Hanneke M. [2 ,3 ]
Wind, Anne E. [2 ,3 ]
van der Vis, Joanne J. [2 ,3 ,4 ]
Kampen, Maarten J. [2 ,3 ]
Custers, Jan W. H. [1 ]
Spruit, Martijn A. [5 ,6 ,7 ]
Veltkamp, Marcel [2 ,3 ,8 ]
机构
[1] Univ Appl Sci Utrecht, Inst Movement Studies, Fac Hlth Care, Utrecht, Netherlands
[2] St Antonius Hosp, Interstitial Lung Dis Ctr Excellence, Dept Pulmonol, Nieuwegein, Netherlands
[3] European Reference Network Lung, Nieuwegein, Netherlands
[4] St Antonius Hosp, Dept Clin Chem, Nieuwegein, Netherlands
[5] CIRO, Dept Res & Dev, Horn, Netherlands
[6] Maastricht Univ Med Ctr MUMC, Dept Resp Med, Maastricht, Netherlands
[7] Fac Hlth Med & Life Sci, NUTRIM, Inst Nutr & Translat Res Metab, Maastricht, Netherlands
[8] Univ Med Ctr Utrecht, Div Heart & Lungs, Utrecht, Netherlands
关键词
Idiopathic pulmonary fibrosis (IPF); 6-min walk test (6MWT); Functional exercise capacity; Prognostic; Physiotherapy; GAP (Gender-Age-Physiology) model; CLINICAL-PRACTICE; DISTANCE; SURVIVAL; STANDARDIZATION; PIRFENIDONE; MORTALITY; SOCIETY; UPDATE;
D O I
10.1016/j.rmed.2024.107862
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Idiopathic pulmonary fibrosis (IPF) is a fatal progressive fibrosing lung disease. A decreased 6-min walk distance (6MWD) and exercise-induced oxygen desaturation measured during the 6-min walk test (6MWT), are known predictors of mortality in patients with IPF. However, the use of antifibrotic drugs showed a survival benefit in IPF. Therefore, this study aimed to evaluate to what extend 6MWT-derived attributes are associated with two-year survival when antifibrotic drugs were introduced as part of standard IPF-care. Methods: This real-world data-study included patients with IPF with a 6MWT between 2015 and 2020, and used composite outcome: mortality or lung transplantation within 2 years of follow-up. Data were collected systematically, including demographics, pulmonary function tests, comorbidities, medications and 6MWT-derived attributes. The prediction attributes of 6MWT were studied with a Cox Proportional-Hazards model and Kaplan-Meier survival curves. The best discriminating attribute to predict mortality was added to the prediction model Gender-Age-Physiology (GAP). Results: In 216 patients, 2-year transplant-free survival cut-off points were identified for the 6MWD (>= 413 m), 6MWD %predicted (>= 83 %), SpO2-nadir (>= 86 %) and distance-saturation-product (>= 374 m%), with the best discriminative value for SpO2-nadir (area under the curve: 0.761). 2-Year survival percentage of patients with SpO2-nadir below or above threshold (86 %) was 37.1 % and 80.0 %, respectively. Exercise-induced oxygen desaturation added to the GAP model showed an improvement in its predictive power. Conclusion: Patients with IPF who have an exercise-induced oxygen desaturation have worse prognosis. Addition of SpO2-nadir to the GAP model seems promising for use in clinical care of IPF patients.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Predictors of the 6-min walk test in patients with ovarian cancer
    Ayse Sezgi Kızılırmak
    Didem Karadibak
    Sukriye Cansu Gultekin
    Ismail Ozsoy
    Husnu Tore Yavuzsen
    Tugba Yavuzsen
    Ilhan Oztop
    Supportive Care in Cancer, 2023, 31
  • [22] Repeatability of the 6-min walk test in non-cystic fibrosis bronchiectasis
    Eidt Rovedder, Paula Maria
    Fernandes, Rafael Oliveira
    Jacques, Patricia Santos
    Ziegler, Bruna
    Andrade, Francini Porcher
    Roth Dalcin, Paulo de Tarso
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [23] Repeatability of the 6-min walk test in non-cystic fibrosis bronchiectasis
    Paula Maria Eidt Rovedder
    Rafael Oliveira Fernandes
    Patrícia Santos Jacques
    Bruna Ziegler
    Francini Porcher Andrade
    Paulo de Tarso Roth Dalcin
    Scientific Reports, 10
  • [24] Gas exchange responses during 6-min walk test in patients with pulmonary arterial hypertension
    Morris, Norman R.
    Seale, Helen
    Harris, Julie
    Hall, Kathleen
    Lin, Aaron C. W.
    Kermeen, Fiona
    RESPIROLOGY, 2017, 22 (01) : 165 - 171
  • [25] Kinematic evaluation of patients with chronic obstructive pulmonary disease during the 6-min walk test
    Saraiva, Nathalia Alves Oliveira
    Ferreira, Arthur Sa
    Papathanasiou, Jannis Vasileios
    Guimaraes, Fernando Silva
    Lopes, Agnaldo Jose
    JOURNAL OF BODYWORK AND MOVEMENT THERAPIES, 2021, 27 : 134 - 140
  • [26] The Value and Application of the 6-Minute-Walk Test in Idiopathic Pulmonary Fibrosis
    Brown, A. Whitney
    Nathan, Steven D.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2018, 15 (01) : 3 - 10
  • [27] The 6-Min Walk Test in Pulmonary Arterial Hypertension: Only for Bad News?
    Deboeck, Gael
    RESPIRATION, 2015, 89 (05) : 363 - 364
  • [28] The 6-min walk test: a useful test in elderly patients with heart failure?
    Ingle, Lee
    Carroll, Sean
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2007, 39 (02): : 391 - 391
  • [29] The 6-min walk test in assessment for mortality in patients with heart failure
    Grundtvig, M.
    Eriksen-Volnes, T.
    Helgesen, E-B H.
    Hansen, M. E.
    Gullestad, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 217 - 217
  • [30] Prognostic Significance and Determinants of the 6-Min Walk Test in Patients With Heart Failure and Preserved Ejection Fraction
    Zotter-Tufaro, Caroline
    Mascherbauer, Julia
    Duca, Franz
    Koell, Benedikt
    Aschauer, Stefan
    Kammerlander, Andreas A.
    Panzenboeck, Adelheid
    Sadushi-Kolici, Roela
    Bangert, Christine
    Laimer, Daniela
    Ristl, Robin
    Lang, Irene M.
    Bonderman, Diana
    JACC-HEART FAILURE, 2015, 3 (06) : 459 - 466